We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Pushing Drug Discovery Forward

News   Dec 14, 2015

 
Pushing Drug Discovery Forward
 
 
Advertisement
 

RELATED ARTICLES

SARS-CoV-2 Immunity Rapidly Declines Within Months of Infection

News

A recent preprint study indicates that there is a rapid decline in the levels of SARS-CoV-2 neutralizing antibodies during the weeks following initial infection. This raises questions over the potential for re-infection, the effectiveness that may be expected from vaccination and the viable window for antibody testing in disease surveillance.

READ MORE

Why Lopinavir and Hydroxychloroquine Are Ineffective in COVID-19 Patients

News

A research group has discovered that the concentration of lopinavir and hydroxychloroquine in the lungs of COVID-19 patients is not sufficient to fight the virus.

READ MORE

Additional Data Announced on Use of Remdesivir for Treatment of COVID-19

News

Gilead Sciences, Inc. has announced additional data on the use of remdesivir, an investigational antiviral, for the treatment of COVID-19.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE